Literature DB >> 8496544

Generalized arteriopathy in Williams syndrome: an intravascular ultrasound study.

A J Rein1, T J Preminger, S B Perry, J E Lock, S P Sanders.   

Abstract

OBJECTIVES: We used intraluminal ultrasound imaging to provide additional information about the vascular pathology in Williams syndrome.
BACKGROUND: The cardiovascular pathology of Williams syndrome consists of medial hypertrophy in both systemic and pulmonary arteries, which results in lumen narrowing.
METHODS: Systemic and pulmonary arteries were examined in vivo using intravascular ultrasound imaging (5F, 30-MHz catheter) in three children with Williams syndrome.
RESULTS: All arteries exhibited severe wall thickening with secondary lumen narrowing. Balloon dilation of a branch pulmonary artery in two children resulted in a significant localized increase in lumen caliber associated with a tear in the vessel wall.
CONCLUSIONS: Intravascular ultrasound imaging in patients with Williams syndrome may permit better understanding of the pathophysiology of the syndrome and a more rational approach to therapeutic interventions.

Entities:  

Mesh:

Year:  1993        PMID: 8496544     DOI: 10.1016/0735-1097(93)90394-g

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Induced chromosome deletion in a Williams-Beuren syndrome mouse model causes cardiovascular abnormalities.

Authors:  Craig J Goergen; Hong-Hua Li; Uta Francke; Charles A Taylor
Journal:  J Vasc Res       Date:  2010-10-07       Impact factor: 1.934

2.  Mechanical properties of the common carotid artery in Williams syndrome.

Authors:  Y Aggoun; D Sidi; B I Levy; S Lyonnet; J Kachaner; D Bonnet
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

3.  Drug-Coated Balloon Angioplasty: A Novel Treatment for Pulmonary Artery In-Stent Stenosis in a Patient with Williams Syndrome.

Authors:  Jennifer L Cohen; Julie S Glickstein; Matthew A Crystal
Journal:  Pediatr Cardiol       Date:  2017-06-07       Impact factor: 1.655

4.  Comparison of normal and diseased pulmonary artery morphology by intravascular ultrasound and histological examination.

Authors:  P Stähr; H J Rupprecht; T Voigtländer; M Otto; K Rudigier; R Erbel; P Kearney; J Meyer
Journal:  Int J Card Imaging       Date:  1999-06

5.  Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome.

Authors:  Zsolt Urbán; Sheila Riazi; Thomas L Seidl; Jodi Katahira; Leslie B Smoot; David Chitayat; Charles D Boyd; Aleksander Hinek
Journal:  Am J Hum Genet       Date:  2002-05-06       Impact factor: 11.025

6.  Stenosis of the thoracic aorta in Williams syndrome.

Authors:  R Thomas Collins; Paige Kaplan; Jonathan J Rome
Journal:  Pediatr Cardiol       Date:  2010-04-22       Impact factor: 1.655

Review 7.  Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome.

Authors:  Barbara R Pober; Mark Johnson; Zsolt Urban
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

8.  Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren Syndrome.

Authors:  Victoria Campuzano; Maria Segura-Puimedon; Verena Terrado; Carolina Sánchez-Rodríguez; Mathilde Coustets; Mauricio Menacho-Márquez; Julián Nevado; Xosé R Bustelo; Uta Francke; Luis A Pérez-Jurado
Journal:  PLoS Genet       Date:  2012-02-02       Impact factor: 5.917

Review 9.  Elastic tissue disruption is a major pathogenic factor to human vascular disease.

Authors:  María M Adeva-Andany; Lucía Adeva-Contreras; Carlos Fernández-Fernández; Manuel González-Lucán; Raquel Funcasta-Calderón
Journal:  Mol Biol Rep       Date:  2021-06-15       Impact factor: 2.316

10.  High prevalence of cardiovascular risk factors in children and adolescents with Williams-Beuren syndrome.

Authors:  Daiji Takeuchi; Michiko Furutani; Yuriko Harada; Yoshiyuki Furutani; Kei Inai; Toshio Nakanishi; Rumiko Matsuoka
Journal:  BMC Pediatr       Date:  2015-09-17       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.